Stem Cell Therapy for Retinitis Pigmentosa in United Arab Emirates

Recent strides in stem cell therapy for Retinitis Pigmentosa (RP) have marked significant advancements. This innovative treatment involves implanting stem cells through efficient delivery routes, like retrobulbar administration, enhancing treatment efficacy. Specialized eye stem cell centers now provide cutting-edge facilities tailored for addressing various eye conditions, particularly RP.

RP, an inherited ocular disease leading to blindness, exhibits symptoms such as impaired night vision and gradual peripheral vision loss, often resulting in tunnel vision. It typically runs in families, attributed to mutations in over 50 genes. The condition primarily stems from the progressive degeneration of rod photoreceptor cells at the eye’s posterior, subsequently impacting cone photoreceptor cells responsible for colour perception and central vision.

Our medical experts affirm that retinitis pigmentosa is commonly hereditary, and frequently passed down from parents to their children. Symptoms may manifest during childhood in some cases, while in others, the condition might affect vision at a later stage of life. Beyond providing stem cell therapy, we prioritize a comprehensive understanding of each individual’s condition, ensuring tailored and precise treatments for better outcomes.

Stem Cell Treatment in the United Arab Emirates:

Stem cell therapy in United Arab Emirates revolves around the replacement of damaged cells or tissues with repaired ones derived from stem cells. These versatile cells can be obtained from various sources such as umbilical cord tissue derived mesenchymal stem cells, bone marrow derived mononuclear cells transplants. This therapeutic approach has exhibited efficacy in treating diverse conditions, notably blood disorders, by targeting cancerous cells.

The essence of stem cell therapy lies in expediting recovery through the introduction of healthy cells into the body, offering substantial and noteworthy benefits to individuals undergoing this transformative treatment.

How Retinitis Pigmentosa Cured:

In the Phase I/II clinical trial conducted for Retinitis Pigmentosa Treatment, an experimental stem cell-based therapy has showcased a positive safety profile, aimed at preserving and potentially enhancing eyesight in individuals with RP. This marks a notable milestone as one of the initial stem cell-derived treatments for RP, making the safety data particularly significant. The overseeing Foundation foresees further insights and breakthroughs as the trial progresses in the upcoming years.

Retinitis Pigmentosa entails progressive vision deterioration leading to eventual blindness as individuals age. It encompasses a spectrum of genetic disorders inherited from either parent. RP-associated conditions include Usher syndrome, Leber’s congenital amaurosis (LCA), Rod-cone disease, and Bardet-Biedl syndrome.

Stem cell therapy in United Arab Emirates facilitated by the Eye Stem Cell Center, mirrors our unwavering dedication to providing exceptional patient care. Outfitted with state-of-the-art technology and advanced equipment, our centre ensures the delivery of cutting-edge treatments. Patients receiving care at the Eye Stem Cell Center can anticipate superior outcomes, benefitting from our commitment to pioneering advancements in Retinitis Pigmentosa treatment.